Phibro Animal Health Corporation
PAHC
$41.88
-$1.35-3.12%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.71% | 27.37% | 19.12% | 12.63% | 7.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.71% | 27.37% | 19.12% | 12.63% | 7.17% |
| Cost of Revenue | 33.35% | 26.49% | 15.80% | 10.09% | 5.59% |
| Gross Profit | 34.50% | 29.34% | 26.75% | 18.44% | 10.78% |
| SG&A Expenses | 16.08% | 9.00% | 23.43% | 19.80% | 17.08% |
| Depreciation & Amortization | -20.46% | -20.46% | -1.94% | -1.94% | -1.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.86% | 21.82% | 14.45% | 9.30% | 4.54% |
| Operating Income | 88.11% | 110.75% | 87.81% | 62.21% | 49.28% |
| Income Before Tax | 191.07% | 522.87% | 94.82% | 20.11% | -11.34% |
| Income Tax Expenses | 77.54% | 132.11% | 46.73% | 8.54% | -5.21% |
| Earnings from Continuing Operations | 289.61% | 1,897.68% | 141.54% | 30.53% | -16.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 289.61% | 1,897.68% | 141.54% | 30.53% | -16.05% |
| EBIT | 88.11% | 110.75% | 87.81% | 62.21% | 49.28% |
| EBITDA | 73.53% | 81.21% | 64.19% | 44.75% | 33.40% |
| EPS Basic | 289.39% | 1,895.64% | 141.45% | 30.51% | -16.04% |
| Normalized Basic EPS | 130.78% | 341.65% | 148.55% | 66.71% | 32.16% |
| EPS Diluted | 290.50% | 2,010.34% | 141.82% | 31.21% | -16.42% |
| Normalized Diluted EPS | 129.72% | 340.53% | 147.64% | 66.30% | 31.98% |
| Average Basic Shares Outstanding | 0.03% | 0.01% | 0.01% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.49% | 0.36% | 0.36% | 0.25% | 0.12% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.74% | -0.95% | -0.59% | -0.23% | 0.19% |